ZA9811655B - Phenylaminoalkylcarboxylic acid derivatives and pharmaceutical compositions comprising the same - Google Patents

Phenylaminoalkylcarboxylic acid derivatives and pharmaceutical compositions comprising the same

Info

Publication number
ZA9811655B
ZA9811655B ZA9811655A ZA9811655A ZA9811655B ZA 9811655 B ZA9811655 B ZA 9811655B ZA 9811655 A ZA9811655 A ZA 9811655A ZA 9811655 A ZA9811655 A ZA 9811655A ZA 9811655 B ZA9811655 B ZA 9811655B
Authority
ZA
South Africa
Prior art keywords
same
pharmaceutical compositions
acid derivatives
phenylaminoalkylcarboxylic acid
phenylaminoalkylcarboxylic
Prior art date
Application number
ZA9811655A
Other languages
English (en)
Inventor
Tetsuro Tamai
Nobuyuki Tanaka
Harunobu Mukaiyama
Akihito Hirabayashi
Hideyuki Muranaka
Masaaki Sato
Masuo Akahane
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of ZA9811655B publication Critical patent/ZA9811655B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/18—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9811655A 1997-12-18 1998-12-18 Phenylaminoalkylcarboxylic acid derivatives and pharmaceutical compositions comprising the same ZA9811655B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP37008797 1997-12-18

Publications (1)

Publication Number Publication Date
ZA9811655B true ZA9811655B (en) 1999-06-23

Family

ID=18496040

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9811655A ZA9811655B (en) 1997-12-18 1998-12-18 Phenylaminoalkylcarboxylic acid derivatives and pharmaceutical compositions comprising the same

Country Status (23)

Country Link
US (1) US6353025B1 (de)
EP (1) EP1043308B1 (de)
JP (1) JP4156799B2 (de)
KR (1) KR100545474B1 (de)
AR (1) AR017858A1 (de)
AT (1) ATE250570T1 (de)
AU (1) AU754317B2 (de)
CA (1) CA2315235C (de)
CO (1) CO5070654A1 (de)
CZ (1) CZ296433B6 (de)
DE (1) DE69818516T2 (de)
ES (1) ES2209226T3 (de)
HU (1) HUP0100102A3 (de)
IL (1) IL136612A (de)
MY (1) MY120466A (de)
NO (1) NO20003105L (de)
NZ (1) NZ505103A (de)
PE (1) PE20000131A1 (de)
PL (1) PL341221A1 (de)
SA (1) SA99191012B1 (de)
TW (1) TW503229B (de)
WO (1) WO1999031045A1 (de)
ZA (1) ZA9811655B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1072583B1 (de) 1998-04-14 2004-09-01 Kissei Pharmaceutical Co., Ltd. 2-methylpropionsäure-derivate und sie enthaltende medizinische zubereitungen
US20030018061A1 (en) * 2000-01-28 2003-01-23 Kohei Ogawa Novel remedies with the use of beta 3 agonist
TWI249515B (en) 2001-11-13 2006-02-21 Theravance Inc Aryl aniline beta2 adrenergic receptor agonists
US6653323B2 (en) 2001-11-13 2003-11-25 Theravance, Inc. Aryl aniline β2 adrenergic receptor agonists
RU2321401C2 (ru) * 2002-11-07 2008-04-10 Астеллас Фарма Инк. Лекарственное средство против гиперактивного мочевого пузыря, включающее производное анилида уксусной кислоты в качестве активного ингредиента
EP1424079A1 (de) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Kombination eines beta-3-Rezeptoragonisten und eines Serotonin und/oder Norepinephrin-Wiederaufnahmeinhibitors
JPWO2004106283A1 (ja) * 2003-05-28 2006-07-20 キッセイ薬品工業株式会社 アミノアルコール誘導体、それを含有する医薬組成物およびそれらの用途
CN1993357B (zh) 2004-07-02 2011-10-19 伯拉考成像股份公司 用于磁共振成像(mri)的含有具有多羟基化取代基的螯合部分的高弛豫造影剂
US8109981B2 (en) 2005-01-25 2012-02-07 Valam Corporation Optical therapies and devices
TWI478712B (zh) 2008-09-30 2015-04-01 Astellas Pharma Inc 釋控性醫藥組成物
JPWO2010041569A1 (ja) 2008-10-09 2012-03-08 旭化成ファーマ株式会社 インダゾール化合物
EP2351742A4 (de) 2008-10-09 2012-03-28 Asahi Kasei Pharma Corp Indazolderivate
US20100222404A1 (en) * 2008-11-04 2010-09-02 Asahi Kasei Pharma Corporation Indazole derivative dihydrochloride
WO2011122524A1 (ja) 2010-03-29 2011-10-06 アステラス製薬株式会社 放出制御医薬組成物
US12097189B1 (en) 2024-02-09 2024-09-24 Astellas Pharma Inc. Pharmaceutical composition for modified release

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146638A (en) * 1976-02-17 1979-03-27 Boehringer Ingelheim Gmbh N-(3-phenoxy-2-hydroxy-propyl)-n-(2-phenyl-2-hydroxy-ethyl)-amines
EP0068669A1 (de) 1981-06-20 1983-01-05 Beecham Group Plc Sekundäre Phenyläthanolamine, Verfahren zu deren Herstellung und deren pharmazeutische Verwendung
ZA835126B (en) * 1982-07-16 1984-06-27 Beecham Group Plc Secondary amines
DE3368258D1 (en) 1982-07-16 1987-01-22 Beecham Group Plc 2-aminoethyl ether derivatives, processes for their preparation and pharmaceutical compositions containing them
GB8528633D0 (en) 1985-11-21 1985-12-24 Beecham Group Plc Compounds

Also Published As

Publication number Publication date
WO1999031045A1 (en) 1999-06-24
AR017858A1 (es) 2001-10-24
KR20010024747A (ko) 2001-03-26
EP1043308A4 (de) 2001-11-14
PE20000131A1 (es) 2000-03-15
JP4156799B2 (ja) 2008-09-24
DE69818516D1 (de) 2003-10-30
EP1043308A1 (de) 2000-10-11
NZ505103A (en) 2003-03-28
IL136612A (en) 2003-11-23
NO20003105L (no) 2000-08-17
MY120466A (en) 2005-10-31
AU754317B2 (en) 2002-11-14
IL136612A0 (en) 2001-06-14
EP1043308B1 (de) 2003-09-24
PL341221A1 (en) 2001-03-26
KR100545474B1 (ko) 2006-01-24
AU1506199A (en) 1999-07-05
SA99191012B1 (ar) 2006-07-03
TW503229B (en) 2002-09-21
HUP0100102A2 (hu) 2001-05-28
ATE250570T1 (de) 2003-10-15
CA2315235A1 (en) 1999-06-24
CA2315235C (en) 2009-07-28
CZ20002244A3 (cs) 2000-11-15
NO20003105D0 (no) 2000-06-16
ES2209226T3 (es) 2004-06-16
CO5070654A1 (es) 2001-08-28
US6353025B1 (en) 2002-03-05
HUP0100102A3 (en) 2002-11-28
CZ296433B6 (cs) 2006-03-15
DE69818516T2 (de) 2004-07-08

Similar Documents

Publication Publication Date Title
IL135177A0 (en) Amidocarboxylic acid derivatives and pharmaceutical compositions containing the same
HUP0100178A3 (en) Tetrahydro-naphtiridinyl-imidazolydinyl-carboxylic acid derivatives and pharmaceutical compositions thereof
IL138899A0 (en) Amidene derivatives and pharmaceutical compositions containing the same
IL140862A0 (en) Thiobenzimidazole derivatives and pharmaceutical compositions containing the same
IL135589A0 (en) Aminothiazole derivatives and pharmaceutical compositions containing the same
IL136941A0 (en) Sulphonamide derivatives and pharmaceutical compositions containing the same
IL136940A0 (en) Sulphonamide derivatives and pharmaceutical compositions containing the same
IL135176A0 (en) Benzothiazole derivatives and pharmaceutical compositions containing the same
IL131319A0 (en) 3-Piperidyl-4- oxoquinazoline derivatives and medicinal compositions containing the same
IL144977A0 (en) Pyrrolotriazine derivatives and pharmaceutical compositions containing the same
HUP0003761A3 (en) Substituted alkanohydroxamic acids and pharmaceutical compositions containing them
HUP0103406A3 (en) 1h-imidazopyridine derivatives and pharmaceutical compositions thereof
IL136044A0 (en) 2-aminoacetamide derivatives and pharmaceutical compositions containing the same
IL143920A0 (en) 3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same
IL123887A0 (en) Dithiolan derivatives their use and pharmaceutical compositions containing the same
HUP0102990A3 (en) Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof
HUP0004398A3 (en) Alpha-aryl-n-alkylnitrones and pharmaceutical compositions containing the same
IL133097A0 (en) Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof
HUP0102766A3 (en) Aminomethylcarboxylic acid derivatives, their pharmaceutical use and pharmaceutical compositions comprising them
PL345730A1 (en) Phenoxyacetic acid derivatives and medicinal compositions containing the same
ZA982872B (en) Pharmaceutical formulation
HUP0001269A3 (en) 2-oxo-1-azetidine sulfonic acid derivatives and combined pharmaceutical compositions thereof
HUP0103203A3 (en) Azaadamantane derivatives and pharmaceutical compositions thereof
IL147214A0 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same
HUP0100085A3 (en) Biphenylamidine derivatives and pharmaceutical compositions containing them